GlassScriptPhysician profile
Chloe Y Shin
NPI 1710522180
$4,161.35
in general payments reported to CMS, 2019-2025
11 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $645 · 2023: $565 · 2024: $1,581 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,078 · Education: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,077.63 |
| Education | $297.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $768.96 | 2021-2025 | Tremfya |
| Abbvie INC. | $702.63 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $662.78 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $614.30 | 2021-2025 | |
| Amgen INC. | $555.70 | 2022-2025 | Enbrel, Otezla, Otezla |
| Aurinia Pharma U.S., INC. | $427.22 | 2022-2024 | Lupkynis |
| Astrazeneca Pharmaceuticals LP | $135.70 | 2024-2025 | Saphnelo |
| Glaxosmithkline, LLC. | $129.61 | 2024-2025 | Benlysta |
| Ucb, INC. | $96.14 | 2025 | Bimzelx |
| Medtronic, INC. | $52.18 | 2023 | Mycarelink, Minimed 780g |
| Teva Pharmaceuticals USA, INC. | $16.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chloe Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.